• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBCR081002A
Device Problem Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/15/2024
Event Type  malfunction  
Event Description
The following was reported to gore: on (b)(6) 2024, the patient underwent treatment for restenosis in an arterial graft (unknown manufacturer) segment using a gore® viabahn® endoprosthesis (viabahn device) in an unknown anatomical location.It was reported the physician was able to reach the target treatment zone by tracking the viabahn device over a terumo glidewire and through a merit medical 8 fr prelude introducer sheath.When it came time for the physician to pull on the deployment line, they were unable to pull the deployment line all the way.However, there was some device expansion at the distal end.The physician noticed under fluoroscopy that the sheath was not covering the viabahn device while it was partially expanding.The physician decided to withdraw the viabahn device through the introducer sheath and became stuck in the sheath.The physician then removed the sheath with the viabahn device inside along with the guidewire.The procedure was completed using another viabahn device with a new 8 fr sheath.There was no impact to the patient.
 
Manufacturer Narrative
H6: code b14 - a review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.H6: code c21 - investigation is pending completion of product evaluation.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Manufacturer Narrative
H6: engineering evaluation the engineering evaluation report details observations made directly on the returned device in addition to device photos captured during evaluation.Engineering evaluation of the device confirms the reported failure mode of stuck deployment line.The root cause of the reported failure mode of stuck deployment line could not be established with the available information.The root cause of observed device damage during engineering evaluation is consistent with attempted withdrawal of partially expanded endoprosthesis into introducer sheath and other manipulation of device during procedure.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.H6: removed code d16 and added codes d15 and d1002 under investigation conclusions.D9: added date when device was returned to manufacture for an evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
vanessa rodriguez
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18673121
MDR Text Key335444874
Report Number2017233-2024-04615
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberVBCR081002A
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/15/2024
Initial Date FDA Received02/08/2024
Supplement Dates Manufacturer Received05/09/2024
Supplement Dates FDA Received05/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-